Ctt Pharmaceutical Holdings reported cash from operations of -$0.02M and free cash flow of -$0.02M for the quarter ended Sep 2014, up 0.7% year over year. This cash flow statement covers 18 quarters of results from Jun 2010 through Sep 2014, standardized by Business Quant from the company’s SEC filings.
| Cash Flow StatementCash Flow | Jun2010 | Sep2010 | Dec2010 | Mar2011 | Jun2011 | Sep2011 | Dec2011 | Mar2012 | Jun2012 | Sep2012 | Dec2012 | Mar2013 | Jun2013 | Sep2013 | Dec2013 | Mar2014 | Jun2014 | Sep2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||||
| Net Income | 0.00M | -0.87M | -0.06M | 5.69M | -1.08M | -0.44M | -0.43M | -0.58M | -0.04M | -0.11M | -0.18M | -0.04M | -0.06M | -0.01M | -0.01M | 0.00M | -920.00 | -0.04M |
| Depreciation, Depletion & Amortization | ||||||||||||||||||
| Depreciation & Amortization (CF)Dep. & Amort. | 0.02M | 0.02M | 0.00M | |||||||||||||||
| Share-based CompensationStock Comp. | 0.01M | 0.13M | 0.16M | 0.04M | ||||||||||||||
| Gains from Equity InvestmentsGains Equity | -0.26M | -0.68M | -0.36M | -0.23M | ||||||||||||||
| Gains from Investment SecuritiesGains Investment | 0.32M | 0.16M | 0.02M | 0.02M | 0.02M | |||||||||||||
| Other non-cash itemsOther Non-Cash | -0.38M | -0.10M | 0.03M | 0.06M | -0.03M | -0.02M | -520.00 | -390.00 | 934.00 | 0.01M | 228.00 | 0.01M | 0.00M | 474.00 | 0.00M | 907.00 | 0.02M | |
| Change in Working Capital | ||||||||||||||||||
| Change in ReceivablesChange Receivables | 0.01M | 0.09M | 0.05M | -0.46M | 0.17M | 0.02M | -0.01M | -698.00 | 0.00M | 0.00M | -69.00 | |||||||
| Change in Accured ExpensesChange Accured Exp. | 0.16M | -0.12M | 0.44M | 0.01M | 0.27M | -0.06M | 0.74M | -0.09M | -0.11M | -0.02M | -0.01M | -0.02M | 0.00M | -0.01M | -0.04M | 436.00 | -0.02M | 0.01M |
| Change in Other Operating AssetsOther Assets Change | 0.09M | 0.15M | -0.06M | -0.01M | -0.01M | -0.01M | 0.17M | -0.13M | -0.03M | 0.01M | -0.01M | -0.01M | -0.01M | 0.00M | ||||
| Other Working Capital ChangesOther WC Changes | -0.09M | -0.15M | 0.06M | 0.01M | 0.01M | 0.01M | -0.17M | 0.13M | 0.03M | -0.01M | 0.01M | 0.01M | 0.01M | 0.00M | ||||
| Cash from OperationsCash from Ops. | -0.29M | -1.03M | -0.24M | -0.01M | 0.47M | -0.16M | 0.20M | -0.52M | -0.26M | -0.16M | -0.09M | -0.07M | -0.03M | -0.02M | -0.14M | -330.00 | -0.03M | -0.02M |
| Investing Activities | ||||||||||||||||||
| Capital ExpendituresCapex | 0.10M | |||||||||||||||||
| Change in Property, Plant and EquipmentChange in PP&E | -0.10M | |||||||||||||||||
| Sale and Maturity of InvestmentsInvestments Sold | 1.01M | 0.20M | 0.03M | 0.04M | 0.18M | |||||||||||||
| Cash from Investing ActivitiesCash from Investing | 0.41M | -0.44M | 0.10M | 0.22M | 0.05M | 0.07M | 0.08M | 0.02M | 0.02M | 0.12M | 0.03M | -0.15M | 0.27M | |||||
| Financing Activities | ||||||||||||||||||
| Debt Issuance and Repayment | ||||||||||||||||||
| Long-Term Debt IssuancesLT Debt Issuance | -0.19M | -0.09M | 0.18M | |||||||||||||||
| Non-Current Debt | -0.19M | -0.09M | 0.18M | 0.20M | 0.03M | 0.02M | 0.03M | -0.10M | 0.02M | 0.02M | 0.00M | 0.00M | -0.15M | |||||
| Net Debt Issuances and RepaymentsNet Debt Issuance | -0.19M | -0.09M | 0.18M | 0.20M | 0.03M | 0.02M | 0.03M | -0.10M | 0.02M | 0.02M | 0.00M | 0.00M | -0.15M | |||||
| Change in Capital Stock | ||||||||||||||||||
| Common Stock IssuedStock Issued | 0.01M | 0.10M | 0.03M | |||||||||||||||
| Net Shares Issued and RepurchasedNet Shares Issued | 0.01M | 0.10M | 0.03M | |||||||||||||||
| Net Equity Issued and RepurchasedNet Equity Issued | 0.01M | 0.10M | 0.03M | |||||||||||||||
| Cash from Financing ActivitiesCash from Financing | -0.19M | -0.09M | 0.05M | 0.11M | 0.03M | 0.00M | 0.39M | 0.00M | ||||||||||
| Additional items | ||||||||||||||||||
| Exchange Rate EffectFX Effect | -0.03M | 0.17M | ||||||||||||||||
| Change in Cash | -0.51M | -0.96M | -0.32M | 0.40M | 0.47M | -0.16M | -0.13M | -0.39M | -0.04M | -0.11M | -0.02M | 0.01M | -0.01M | -0.01M | -0.01M | 0.00M | 0.21M | 0.12M |
| Free Cash FlowFCF | -0.29M | -1.03M | -0.24M | -0.01M | 0.47M | -0.16M | 0.20M | -0.62M | -0.26M | -0.16M | -0.09M | -0.07M | -0.03M | -0.02M | -0.14M | -330.00 | -0.03M | -0.02M |
| Net Cash FlowNCF | -0.48M | -1.12M | -0.19M | 0.40M | 0.47M | -0.16M | -0.13M | -0.39M | -0.04M | -0.11M | -0.02M | 0.01M | -0.01M | -0.01M | -0.01M | 0.03M | 0.21M | 0.24M |
Pull Ctt Pharmaceutical Holdings's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=CTTH&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "CTTH", "statement": "CF", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=CTTH&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();